What's the Tariff on Pharmaceuticals?
Active pharmaceutical ingredients from India and China.
Current Tariff Rate
10%
Pre-2025 Rate
0%
Rate Increase
+10pp
Price Impact
+10%
+$10
Real-World Price Impact
Before Tariffs
$100
Rx drug ingredients
After Tariffs
$110
Rx drug ingredients
That's $10 more per unit — a 10% price increase paid by the American buyer.
Note: Price estimates assume full tariff pass-through to consumers. Actual retail prices may vary — manufacturers may absorb some costs, shift production, or adjust margins.
The Story Behind This Tariff
Pharmaceutical tariffs expose America's dangerous dependency on foreign drug manufacturing — a vulnerability laid bare during COVID-19 supply chain disruptions. India produces 40% of US generic drug supply, while China manufactures 80% of active pharmaceutical ingredients (APIs) used globally. The 10% Section 122 tariff on finished drugs and ingredients is deliberately modest — policymakers fear the public health consequences of making medications more expensive. However, even 10% on essential medications creates real costs: insulin, blood pressure drugs, antibiotics, and cancer treatments all rely on imported APIs. The tariff's stated goal is encouraging domestic API production, but building pharmaceutical manufacturing capacity requires 5-7 years of facility construction and FDA approval. In the interim, the tariff functions as a tax on sick people. Generic drug companies operate on razor-thin 3-5% margins, meaning even small tariffs may force some generics off the market entirely.
📦 Supply Chain
Primary Origin
IN
Made in USA
28%
Import Volume
$195B
Alternatives
Ireland (Pfizer, big pharma), domestic expansion (slow)
📅 Tariff Timeline
2018
Pharmaceuticals excluded from Section 301
0%2020
COVID exposes API supply chain vulnerability
0%2025
Section 122 baseline applied to all pharma imports
10%👥 Consumer Impact
Households Affected
130M
Annual Cost Per Household
$120
💡 Did You Know?
- •China manufactures 80% of the world's active pharmaceutical ingredients — the raw materials in nearly every pill Americans take
- •India produces 40% of US generic drugs but sources 70% of its own APIs from China, creating a dependency chain
- •The US cannot currently manufacture common antibiotics like amoxicillin domestically — the last US penicillin plant closed in 2004
Tariff Details
- HTS Code
- 3004.90
- Current Rate
- 10%
- Pre-2025 Rate
- 0%
- Tariff Type
- Section 122
Legal Authority
Section 122 (Balance of Payments)
Effective: April 2025
Baseline 10% tariff on imports to address balance of payments
The tariff on Pharmaceuticals is paid by the American importer at the port of entry and passed through to consumers as higher retail prices. The foreign manufacturer does not pay the tariff.
Who Actually Pays This Tariff?
Despite claims that tariffs are paid by foreign countries, the 10% tariff on Pharmaceuticals is paid by American importers — US companies that purchase these goods from abroad. The cost is then passed to American consumers through higher retail prices.
- ✓ The foreign seller receives the same price as before
- ✓ The US importer pays 10% of the customs value to CBP
- ✓ The retailer marks up the higher landed cost
- ✓ You pay more at the register: $100 → $110
Related Products in Industrial
Steel (Hot-Rolled)
25%
1 ton HR coil: $750 → $938
Aluminum (Unwrought)
25%
1 ton aluminum: $2,400 → $3,000
Semiconductors
50%
Chip batch (1000 units): $5,000 → $7,500
Copper Wire
25%
1000 ft copper wire: $350 → $438
Lithium-Ion Batteries
54%
EV battery pack: $8,000 → $12,320
Solar Panels
54%
10 kW system: $15,000 → $23,100
🔍 Dig Deeper
See the Full Picture
Tariffs affect thousands of products. See how much they're costing your household.